keyword
Keywords Cardiac, hypertension, heart f...

Cardiac, hypertension, heart failure, myocardial infarction

https://read.qxmd.com/read/38788596/decoding-ferroptosis-revealing-the-hidden-assassin-behind-cardiovascular-diseases
#1
REVIEW
Zeyu Zhang, Zhihua Yang, Shuai Wang, Xianliang Wang, Jingyuan Mao
The discovery of regulatory cell death processes has driven innovation in cardiovascular disease (CVD) therapeutic strategies. Over the past decade, ferroptosis, an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, has been shown to drive the development of multiple CVDs. This review provides insights into the evolution of the concept of ferroptosis, the similarities and differences with traditional modes of programmed cell death (e.g., apoptosis, autophagy, and necrosis), as well as the core regulatory mechanisms of ferroptosis (including cystine/glutamate transporter blockade, imbalance of iron metabolism, and lipid peroxidation)...
May 23, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38781602/oral-hormonal-contraceptives-and-cardiovascular-risks-in-females
#2
JOURNAL ARTICLE
Sukhwinder K Bhullar, Inna Rabinovich-Nikitin, Lorrie Kirshenbaum
Oral hormonal contraception (OHC) is a widely employed method in females for the prevention of unintended pregnancies, as well as for the treatment of menstrual disorders, endometriosis, and polycystic ovarian syndrome. However, it is believed that with OHCs use, some females may have higher risk of cardiovascular diseases, such as hypertension, diabetes, myocardial infarction, thrombosis, and heart failure. Although such risks are infrequently detected in healthy young females with the use of oral contraceptives, slightly elevated risks of cardiovascular diseases have been observed among reproductive-aged healthy females...
May 23, 2024: Canadian Journal of Physiology and Pharmacology
https://read.qxmd.com/read/38763105/the-roles-of-b-cells-in-cardiovascular-diseases
#3
REVIEW
Jian Ma, Xiaotong Wang, Yuewang Jia, Fangyan Tan, Xin Yuan, Jianlin Du
Damage to the heart can start the repair process and cause cardiac remodeling. B cells play an important role in this process. B cells are recruited to the injured place and activate cardiac remodeling through secreting antibodies and cytokines. Different types of B cells showed specific functions in the heart. Among all types of B cells, heart-associated B cells play a vital role in the heart by secreting TGFβ1. B cells participate in the activation of fibroblasts and promote cardiac fibrosis. Four subtypes of B cells in the heart revealed the relationship between the B cells' heterogeneity and cardiac remodeling...
May 18, 2024: Molecular Immunology
https://read.qxmd.com/read/38762623/development-and-validation-of-machine-learning-algorithms-based-on-electrocardiograms-for-cardiovascular-diagnoses-at-the-population-level
#4
JOURNAL ARTICLE
Sunil Vasu Kalmady, Amir Salimi, Weijie Sun, Nariman Sepehrvand, Yousef Nademi, Kevin Bainey, Justin Ezekowitz, Abram Hindle, Finlay McAlister, Russel Greiner, Roopinder Sandhu, Padma Kaul
Artificial intelligence-enabled electrocardiogram (ECG) algorithms are gaining prominence for the early detection of cardiovascular (CV) conditions, including those not traditionally associated with conventional ECG measures or expert interpretation. This study develops and validates such models for simultaneous prediction of 15 different common CV diagnoses at the population level. We conducted a retrospective study that included 1,605,268 ECGs of 244,077 adult patients presenting to 84 emergency departments or hospitals, who underwent at least one 12-lead ECG from February 2007 to April 2020 in Alberta, Canada, and considered 15 CV diagnoses, as identified by International Classification of Diseases, 10th revision (ICD-10) codes: atrial fibrillation (AF), supraventricular tachycardia (SVT), ventricular tachycardia (VT), cardiac arrest (CA), atrioventricular block (AVB), unstable angina (UA), ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), pulmonary embolism (PE), hypertrophic cardiomyopathy (HCM), aortic stenosis (AS), mitral valve prolapse (MVP), mitral valve stenosis (MS), pulmonary hypertension (PHTN), and heart failure (HF)...
May 18, 2024: NPJ Digital Medicine
https://read.qxmd.com/read/38745945/association-of-the-longitudinal-trajectory-of-urinary-albumin-creatinine-ratio-in-diabetic-patients-with-adverse-cardiac-event-risk-a-retrospective-cohort-study
#5
JOURNAL ARTICLE
Hui Li, Yajuan Ren, Yongguang Duan, Peng Li, Yunfei Bian
OBJECTIVE: The baseline urinary albumin/creatinine ratio (uACR) has been proven to be significantly associated with the risk of major adverse cardiac events (MACE). However, data on the association between the longitudinal trajectory patterns of uACR, changes in glycated hemoglobin A1c (HbA1c), and the subsequent risk of MACE in patients with diabetes are sparse. METHODS: This is a retrospective cohort study including 601 patients with type 2 diabetes mellitus (T2DM; uACR < 300 mg/g) admitted to The First Hospital of Shanxi Medical University and The Second Hospital of Shanxi Medical University from January 2015 to December 2018...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38744375/modified-5-item-frailty-index-a-useful-tool-for-assessing-the-impact-of-frailty-on-postoperative-morbidity-and-mortality-following-surgical-fixation-of-thoracolumbar-fractures
#6
JOURNAL ARTICLE
Khaled M Taghlabi, Ahmad A Quaddoura, Arsalan Nisar, Paras Gupta, Lokeshwar S Bhenderu, Jaime R Guerrero, Aboud Tahanis, Isuru A Somawardana, Rijul Nanda, Amir H Faraji
OBJECTIVES: The modified 5-item frailty index (mFI-5) is a comorbidity-based risk stratification tool to predict adverse events following various neurological surgeries. This study aims to quantify the association between increased mFI-5 and postoperative complications and mortality following surgical fixation of traumatic thoracolumbar fractures. METHODS: The 2011-2021 American College of Surgeons - National Surgical Quality Improvement Program (ACS-NSQIP) dataset was used to identify patients undergoing fusion surgeries for thoracolumbar spine fractures...
May 12, 2024: World Neurosurgery
https://read.qxmd.com/read/38736057/role-of-bisoprolol-in-heart-failure-management-a-consensus-statement-from-india
#7
JOURNAL ARTICLE
H K Chopra, Tiny Nair, G S Wander, C K Ponde, Saumitra Ray, Dinesh Khullar, Navin C Nanda, Ravi R Kasliwal, D S Rana, Ashok Kirpalani, J P S Sawhney, Praveen Chandra, Yatin Mehta, Viveka Kumar, S Tewari, A K Pancholia, Vijay Kher, Sandeep Bansal, Sanjay Mittal, Praful Kerkar, P K Sahoo, Ramesh Hotchandani, Sunil Prakash, Nagendra Chauhan, Vishal Rastogi, A Jabir, S Shanmugasundaram, Mangesh Tiwaskar, Ajay Sinha, Vittul Gupta, S S Mishra, S N Routray, A K Omar, Onkar C Swami, Aparna Jaswal, Shamsad Alam, Rajeev Passey, Rajeeve Rajput, Justin Paul, Aditya Kapoor, D Prabhakar, Subhash Chandra, Poonam Malhotra, Vivudh Pratap Singh, Manish Bansal, Priyank Shah, Sanjay Jain, Mohan Bhargava, I B Vijayalakshmi, Kiron Varghaese, Dharmender Jain, Anupam Goel, Namrata Gaur, Rohit Tandon, Asha Moorthy, Sheeba George, V K Katyal, R R Mantri, Rahul Mehrotra, Dilip Bhalla, Vinod Mittal, Sarita Rao, Manish Jagia, Harmeet Singh, Surabhi Awasthi, Ameet Sattur, Rekha Mishra, Anand Pandey, Rajeev Chawla, Shalini Jaggi, Blessy Sehgal, Alok Sehgal, Naresh Goel, Ripen Gupta, Samir Kubba, Abhinav Chhabra, Saurabh Bagga, N R Shastry
In India, heart failure (HF) is an important health concern affecting younger age groups than the western population. A limited number of Indian patients receive guideline-directed medical therapy (GDMT). Selective β-1 blockers (BB) are one of the GDMTs in HF and play an important role by decreasing the sympathetic overdrive. The BB reduces heart rate (HR) reverse the adverse cardiac (both ventricular and atrial), vascular, and renovascular remodeling seen in HF. Bisoprolol, a β-1 blocker, has several advantages and can be used across a wide spectrum of HF presentations and in patients with HF and comorbid conditions such as coronary artery disease (CAD), atrial fibrillation (AF), post-myocardial infarction (MI), uncontrolled diabetes, uncontrolled hypertension, and renal impairment...
December 2023: Journal of the Association of Physicians of India
https://read.qxmd.com/read/38732333/primary-cardiac-intimal-sarcoma-multi-layered-strategy-and-core-role-of-mdm2-amplification-co-amplification-and-mdm2-immunostaining
#8
REVIEW
Claudiu Nistor, Mara Carsote, Anca-Pati Cucu, Mihaela Stanciu, Florina Ligia Popa, Adrian Ciuche, Mihai-Lucian Ciobica
Primary cardiac tumours are relatively uncommon (75% are benign). Across the other 25%, representing malignant neoplasia, sarcomas account for 75-95%, and primary cardiac intimal sarcoma (PCIS) is one of the rarest findings. We aimed to present a comprehensive review and practical considerations from a multidisciplinary perspective with regard to the most recent published data in the specific domain of PCIS. We covered the issues of awareness amid daily practice clinical presentation to ultra-qualified management in order to achieve an adequate diagnosis and prompt intervention, also emphasizing the core role of MDM2 immunostaining and MDM2 genetic analysis...
April 28, 2024: Diagnostics
https://read.qxmd.com/read/38709137/long-term-cardiovascular-outcomes-in-children-and-adolescents-with-hypertension
#9
JOURNAL ARTICLE
Cal H Robinson, Junayd Hussain, Nivethika Jeyakumar, Graham Smith, Catherine S Birken, Allison Dart, Janis Dionne, Anika Garg, Sujane Kandasamy, Sabine Karam, Stacey Marjerrison, Andrew M South, Lehana Thabane, Gita Wahi, Michael Zappitelli, Rahul Chanchlani
IMPORTANCE: Hypertension affects 6% of all children, and its prevalence is increasing. Childhood hypertension tracks into adulthood and is associated with subclinical cardiovascular disease; however, there is a lack of evidence linking childhood hypertension to cardiovascular outcomes, which may contribute to underdiagnosis and undertreatment. OBJECTIVE: To determine the long-term associated risk of major adverse cardiac events (MACE) among children diagnosed with hypertension...
May 6, 2024: JAMA Pediatrics
https://read.qxmd.com/read/38693484/obesity-and-metabolic-syndrome-in-patients-with-heart-failure-with-preserved-ejection-fraction-a-cross-sectional-analysis-of-the-veradigm-cardiology-registry
#10
JOURNAL ARTICLE
Jay P Bae, Lee Kallenbach, David R Nelson, Kevin Lavelle, Jessamine P Winer-Jones, Machaon Bonafede, Masahiro Murakami
BACKGROUND: The proportion of heart failure patients with preserved ejection fraction has been rising over the past decades and has coincided with increases in the prevalence of obesity and metabolic syndrome. The relationship between these interconnected comorbidities and heart failure with preserved ejection fraction (HFpEF) is still poorly understood. This study characterized obesity and metabolic syndrome among real-world patients with HFpEF. METHODS: We identified adults with heart failure in the Veradigm Cardiology Registry, previously the PINNACLE Registry, with a left ventricular ejection fraction measurement ≥ 50% between 01/01/2016 and 12/31/2019...
May 1, 2024: BMC Endocrine Disorders
https://read.qxmd.com/read/38657720/genetic-biomarkers-of-cardiovascular-disease
#11
REVIEW
Treesa P Varghese
Cardiovascular disorders are the leading cause mortality in developed as well as developing nations, and has now emerged as one of the leading causes of disability and mortality around the globe. According to the World Health Organization, four out of every five patients with cardiovascular disease die from a myocardial infarction each year. Numerous genes have been linked to coronary artery disease, influencing mechanisms such as blood pressure regulation, lipid metabolism, inflammation, and cardiac activity...
April 22, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38646831/mortality-hospitalization-and-cardiac-interventions-in-patients-with-atrial-fibrillation-aged-65-years
#12
JOURNAL ARTICLE
Aditya Bhonsale, Jianhui Zhu, Floyd Thoma, Steve Koscumb, Krishna Kancharla, Andrew Voigt, Jared Magnani, N A Estes, Samir Saba, Oscar Marroquin, Suresh Mulukutla, Sandeep Jain
BACKGROUND: The risk factor (RF) burden, clinical course, and long-term outcome among patients with atrial fibrillation (AF) aged <65 years is unclear. METHODS: Adult (n=67 221; mean age, 72.4±12.3 years; and 45% female) patients with AF evaluated at the University of Pittsburgh Medical Center between January 2010 and December 2019 were studied. Hospital system-wide electronic health records and administrative data were utilized to ascertain RFs, comorbidities, and subsequent hospitalization and cardiac interventions...
April 22, 2024: Circulation. Arrhythmia and Electrophysiology
https://read.qxmd.com/read/38644919/impact-of-congestive-heart-failure-on-patients-undergoing-lumbar-spine-fusion-for-adult-spine-deformity
#13
JOURNAL ARTICLE
Oluwatobi O Onafowokan, Waleed Ahmad, Kimberly McFarland, Tyler K Williamson, Peter Tretiakov, Jamshaid M Mir, Ankita Das, Joshua Bell, Sara Naessig, Shaleen Vira, Virginie Lafage, Carl Paulino, Bassel Diebo, Andrew Schoenfeld, Hamid Hassanzadeh, Pawel P Jankowski, Aaron Hockley, Peter Gust Passias
BACKGROUND: With the increasing amount of elective spine fusion patients presenting with cardiac disease and congestive heart failure, it is becoming difficult to assess when it is safe to proceed with surgery. Assessing the severity of heart failure (HF) through ejection fraction may provide insight into patients' short- and long-term risks. PURPOSE: The purpose of this study was to assess the severity of HF on perioperative outcomes of spine fusion surgery patients...
2024: Journal of Craniovertebral Junction and Spine
https://read.qxmd.com/read/38643121/the-redox-active-defensive-selenoprotein-t-as-a-novel-stress-sensor-protein-playing-a-key-role-in-the-pathophysiology-of-heart-failure
#14
JOURNAL ARTICLE
Anna De Bartolo, Teresa Pasqua, Naomi Romeo, Vittoria Rago, Ida Perrotta, Francesca Giordano, Maria Concetta Granieri, Alessandro Marrone, Rosa Mazza, Maria Carmela Cerra, Benjamin Lefranc, Jérôme Leprince, Youssef Anouar, Tommaso Angelone, Carmine Rocca
Maladaptive cardiac hypertrophy contributes to the development of heart failure (HF). The oxidoreductase Selenoprotein T (SELENOT) emerged as a key regulator during rat cardiogenesis and acute cardiac protection. However, its action in chronic settings of cardiac dysfunction is not understood. Here, we investigated the role of SELENOT in the pathophysiology of HF: (i) by designing a small peptide (PSELT), recapitulating SELENOT activity via the redox site, and assessed its beneficial action in a preclinical model of HF [aged spontaneously hypertensive heart failure (SHHF) rats] and against isoproterenol (ISO)-induced hypertrophy in rat ventricular H9c2 and adult human AC16 cardiomyocytes; (ii) by evaluating the SELENOT intra-cardiomyocyte production and secretion under hypertrophied stimulation...
April 20, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38633835/clinical-variables-associated-with-major-adverse-cardiac-events-following-radical-cystectomy
#15
JOURNAL ARTICLE
Aaron A Gurayah, Ruben Blachman-Braun, Christopher J Machado, Matthew M Mason, Helen Y Hougen, Ali Mouzannar, Mark L Gonzalgo, Bruno Nahar, Sanoj Punnen, Dipen J Parekh, Chad R Ritch
OBJECTIVES: The objective of this study is to investigate the association between major adverse cardiac events (MACE) and clinical factors of patients undergoing radical cystectomy (RC) for bladder cancer. MATERIALS AND METHODS: A retrospective analysis using the 2015-2020 National Surgical Quality Improvement Program database was performed on patients who underwent RC for bladder cancer. MACE was defined as any report of cerebrovascular accident, myocardial infarction, or thromboembolic events (pulmonary embolism or deep vein thrombosis)...
April 2024: BJUI compass
https://read.qxmd.com/read/38628296/impact-of-the-number-of-modifiable-risk-factors-on-clinical-outcomes-after-percutaneous-coronary-intervention-an-analysis-from-the-e-ultimaster-registry
#16
JOURNAL ARTICLE
Ofer Kobo, Yaniv Levi, Rami Abu-Fanne, Clemens Von Birgelen, Antoine Guédès, Adel Aminian, Peep Laanmets, Willem Dewilde, Adam Witkowski, Jacques Monsegu, Andres Romo Iniguez, Majdi Halabi, Mamas A Mamas, Ariel Roguin
AIMS: A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs): hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs. METHODS: Patients with an indication for a PCI were stratified based upon the number of SMuRFs: 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year...
April 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38615659/metabolic-syndrome-and-cardiac-vessel-remodeling-associated-with-vessel-rarefaction-a-possible-underlying-mechanism-may-result-from-a-poor-angiogenic-response-to-altered-vegf-signaling-pathways
#17
REVIEW
Krzysztof Bartkowiak, Mateusz Bartkowiak, Ewa Jankowska-Steifer, Anna Ratajska, Marek Kujawa, Olga Aniołek, Justyna Niderla-Bielińska
BACKGROUND: Elevated mortality rates in patients with metabolic syndrome (MetS) are partly due to adverse remodeling of multiple organs, which may lead to cardiovascular disease, nonalcoholic fatty liver disease, kidney failure, or other conditions. MetS symptoms, such as obesity, hypertension, hyperglycemia, dyslipidemia, associated with insulin and leptin resistance, are recognized as major cardiovascular risk factors that adversely affect the heart. SUMMARY: Pathological cardiac remodeling is accompanied by endothelial cell dysfunction which may result in diminished coronary flow, dysregulated oxygen demand/supply balance, as well as vessel rarefaction...
April 12, 2024: Journal of Vascular Research
https://read.qxmd.com/read/38571722/the-cardiovascular-changes-underlying-a-low-cardiac-output-with-exercise-in-patients-with-type-2-diabetes-mellitus
#18
REVIEW
Per Lav Madsen, Casper Sejersen, Michael Nyberg, Martin Heyn Sørensen, Ylva Hellsten, Peter Gaede, Annemie Stege Bojer
The significant morbidity and premature mortality of type 2 diabetes mellitus (T2DM) is largely associated with its cardiovascular consequences. Focus has long been on the arterial atheromatosis of DM giving rise to early stroke and myocardial infarctions, whereas less attention has been given to its non-ischemic cardiovascular consequences. Irrespective of ischemic changes, T2DM is associated with heart failure (HF) most commonly with preserved ejection fraction (HFpEF). Largely due to increasing population ages, hypertension, obesity and T2DM, HFpEF is becoming the most prevalent form of heart failure...
2024: Frontiers in Physiology
https://read.qxmd.com/read/38558816/role-of-treg-cell-subsets-in-cardiovascular-disease-pathogenesis-and-potential-therapeutic-targets
#19
REVIEW
Yuanliang Xia, Di Gao, Xu Wang, Bin Liu, Xue Shan, Yunpeng Sun, Dashi Ma
In the genesis and progression of cardiovascular diseases involving both innate and adaptive immune responses, inflammation plays a pivotal and dual role. Studies in experimental animals indicate that certain immune responses are protective, while others exacerbate the disease. T-helper (Th) 1 cell immune responses are recognized as key drivers of inflammatory progression in cardiovascular diseases. Consequently, the CD4+CD25+FOXP3+ regulatory T cells (Tregs) are gaining increasing attention for their roles in inflammation and immune regulation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38555547/addressing-cardiovascular-toxicity-risk-of-electronic-nicotine-delivery-systems-in-the-twenty-first-century-what-are-the-tools-needed-for-the-job-and-do-we-have-them
#20
REVIEW
Mark Chandy, Thomas Hill, Nerea Jimenez-Tellez, Joseph C Wu, S Emma Sarles, Edward Hensel, Qixin Wang, Irfan Rahman, Daniel J Conklin
Cigarette smoking is positively and robustly associated with cardiovascular disease (CVD), including hypertension, atherosclerosis, cardiac arrhythmias, stroke, thromboembolism, myocardial infarctions, and heart failure. However, after more than a decade of ENDS presence in the U.S. marketplace, uncertainty persists regarding the long-term health consequences of ENDS use for CVD. New approach methods (NAMs) in the field of toxicology are being developed to enhance rapid prediction of human health hazards. Recent technical advances can now consider impact of biological factors such as sex and race/ethnicity, permitting application of NAMs findings to health equity and environmental justice issues...
March 31, 2024: Cardiovascular Toxicology
keyword
keyword
113149
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.